Inventor · disambiguated record
Chun Jiang
Also filed as: JIANG CHUN · JIANG CHUN VERNON
16 granted patents·21 pending applications·36 citations·filing 2003–2023
90Inventor score
Files withFERRO THERAPEUTICS INC8MERCK SHARP & DOHME6CALIXA THERAPEUTICS INC3COTHERA BIOSCIENCE INC3K GEN INC3
Top patents by PatentIndex Score
37 records- 0192US9320740B2Ceftolozane-tazobactam pharmaceutical compositionsCUBIST PHARM INC·Filed 2014·Granted Apr 26, 2016·8 cites·21 claims
- 0292US8968753B2Ceftolozane-tazobactam pharmaceutical compositionsCALIXA THERAPEUTICS INC·Filed 2014·Granted Mar 3, 2015·9 cites·30 claims
- 0390US11040964B2Compounds and methods of useFERRO THERAPEUTICS INC·Filed 2020·Granted Jun 22, 2021·4 cites·30 claims
- 0489US9872906B2Ceftolozane antibiotic compositionsMERCK SHARP & DOHME·Filed 2015·Granted Jan 23, 2018·4 cites·20 claims
- 0582US11278622B2Ceftolozane antibiotic compositionsMERCK SHARP & DOHME·Filed 2019·Granted Mar 22, 2022·1 cites·31 claims
- 0680US10420841B2Ceftolozane antibiotic compositionsMERCK SHARP & DOHME·Filed 2017·Granted Sep 24, 2019·1 cites·31 claims
- 0779US9925196B2Ceftolozane-tazobactam pharmaceutical compositionsMERCK SHARP & DOHME·Filed 2016·Granted Mar 27, 2018·1 cites·4 claims
- 0873US11098040B2Compounds and methods of useFERRO THERAPEUTICS INC·Filed 2019·Granted Aug 24, 2021·1 cites·26 claims
- 0971US2015150883A1Ceftolozane-tazobactam pharmaceutical compositionsCALIXA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1070US2024059778A1Combination therapy for cancers with braf mutationCOTHERA BIOSCIENCE INC·Filed 2023·Application pending·0 cites
- 1170US2015045336A1Tazobactam and ceftolozane antibiotic compositionsCALIXA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1269US2018169106A1Ceftolozane-tazobactam pharmaceutical compositionsMERCK SHARP & DOHME·Filed 2018·Application pending·0 cites
- 1365US8022103B2Ester prodrugs of prostratin and related phorbol compoundsSALVIA SCIENCES INC·Filed 2006·Granted Sep 20, 2011·2 cites·40 claims
- 1464US8431612B2Ester prodrugs of prostratin and related phorbol compoundsXU RENSHENG·Filed 2011·Granted Apr 30, 2013·3 cites·20 claims
- 1563US7265129B2Anti-infective biaryl compoundsGENESOFT PHARMACEUTICALS INC·Filed 2003·Granted Sep 4, 2007·1 cites·24 claims
- 1660US2024382476A1Androgen receptor biomarkers for cancer therapyLI XIANG·Filed 2022·Application pending·0 cites
- 1760US2008090816A1Anti-infective biaryl compoundsGENESOFT PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1860US2023039846A1Compounds and methods of useFERRO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1958US2022002280A1Compounds and methods of useFERRO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2058US2024197666A1Diterpenoid compounds that act on protein kinase c (pkc)K GEN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2157US2016279140A1Ceftolozane antibiotic compositionsMERCK SHARP & DOHME·Filed 2016·Application pending·0 cites
- 2256US9879036B2Mitochondrial aldehyde dehydrogenase-2 binding compounds and methods of use thereofAVIV THERAPEUTICS INC·Filed 2015·Granted Jan 30, 2018·1 cites·18 claims
- 2354US2024092739A1Compounds and methods of useFERRO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2453US2023104800A1Combination therapies and biomarkers for treating cancerLI XIANG·Filed 2021·Application pending·0 cites
- 2551US11753476B2Combination therapy for cancers with BRAF mutationCOTHERA BIOSCIENCES INC·Filed 2019·Granted Sep 12, 2023·0 cites·23 claims
- 2650US2024058339A1Combination therapy for cancers with kras mutationCOTHERA BIOSCIENCE INC·Filed 2020·Application pending·0 cites
- 2750US2023310436A1Combination therapy for cancers with kras mutationCOTHERA BIOSCIENCE INC·Filed 2020·Application pending·0 cites
- 2849US9970945B2Compositions, methods, and assays using proteo-liposome-transfected oocytes for analyzing the structure, function, and activity of membrane proteinsUNIV GEORGIA STATE RES FOUND·Filed 2014·Granted May 15, 2018·0 cites·36 claims
- 2949US2012010180A1Soluble dosage forms containing cephem derivatives suitable for parenteral administrationDEDHIYA MAHENDRA G·Filed 2011·Application pending·0 cites
- 3048US2022227765A1Pyrido-indole analogues as gpx4 inhibitorsFERRO THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3147US2022411362A1Diterpenoid compounds that act on protein kinase c (pkc)K GEN INC·Filed 2020·Application pending·0 cites
- 3247US2022227716A1Benzimidazole and hydrogenated carbazole derivatives as gpx4 inhibitorsFERRO THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3346US2022211695A1Morphine-induced respiratory depression: behavioral, phrenic and brainstem respiratory neuronal evidenceUNIV GEORGIA STATE RES FOUND·Filed 2020·Application pending·0 cites
- 3445US2015196572A1Soluble dosage forms containing cephem derivatives suitable for parenteral administrationFOREST LAB HOLDINGS LTD·Filed 2015·Application pending·0 cites
- 3544US2020138829A1Methods of cancer treatmentFERRO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3641US10722484B2Methods of cancer treatmentK GEN INC·Filed 2017·Granted Jul 28, 2020·0 cites·27 claims
- 3737US12502369B2Methods of cancer treatmentK GEN INC·Filed 2016·Granted Dec 23, 2025·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Chun Jiang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →